首页> 外文期刊>OncoTargets and therapy >Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population
【24h】

Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population

机译:MSI / MMR在中国人群中对大肠癌患者生物学行为和预后的预测

获取原文
           

摘要

Colorectal cancers (CRCs) exhibiting microsatellite instability (MSI) have special biological behavior. The clinical predictors for MSI and its survival relevance for the Chinese population were still unclear. Seven hundred ninety-five CRC patients were retrospectively assessed. Mismatch repair (MMR) proteins (MSH2, MSH6, PMS1, and MLH1) expression was detected by immunohistochemistry using tumor tissues of all patients. DNA MSI status was analyzed by polymerase chain reaction in 182 samples randomly selected from the 795 cases. Among all CRC tumor tissues, 97 cases (12.2%) were with an MMR protein-deficient (MMR-D) phenotype, whereas 698 cases (87.8%) were with an MMR proteins intact (MMR-I) phenotype. A total of 21 (11.5%) CRCs were identified as having high microsatellite instability, 156 (85.7%) tumors were having microsatellite stability (MSS), and five (2.7%) were having low microsatellite instability. Importantly, MMR status was demonstrated to be moderately consistent with MSI status (κ=0.845, 95% confidence interval [CI] 0.721, 0.969). Unconditional logistic regression analysis revealed age, number of lymph node, tumor diameter, and tumor site as predictors for MSI with a substantial ability to discriminate different MSI status by area under curve of 80.62% using receiver operation curve. Compared with MMR-I, MMR-D was an independent prognostic factor for longer overall survival (hazard ratio =0.340, 95% CI 0.126, 0.919; P =0.034). MMR-D is an independent prognostic factor for better outcome. Our results may provide evidence for individualized diagnosis and treatment of CRC, but this will require further validation in larger sample studies.
机译:表现出微卫星不稳定性(MSI)的结直肠癌(CRC)具有特殊的生物学行为。 MSI的临床预测指标及其与中国人群的生存相关性尚不清楚。回顾性评估了795例CRC患者。使用所有患者的肿瘤组织通过免疫组织化学检测错配修复(MMR)蛋白(MSH2,MSH6,PMS1和MLH1)的表达。通过聚合酶链反应,从795例病例中随机选择了182个样本,分析了DNA MSI的状况。在所有CRC肿瘤组织中,97例(12.2%)具有MMR蛋白缺陷(MMR-D)表型,而698例(87.8%)具有MMR蛋白完整(MMR-I)表型。总共鉴定出21个(11.5%)的CRC具有较高的微卫星不稳定性,有156个(85.7%)的肿瘤具有微卫星稳定性(MSS),有5个(2.7%)具有较低的微卫星不稳定性。重要的是,已证明MMR状态与MSI状态适度一致(κ= 0.845,95%置信区间[CI] 0.721,0.969)。无条件logistic回归分析显示年龄,淋巴结数目,肿瘤直径和肿瘤部位是MSI的预测因子,具有使用接收器操作曲线根据80.62%的曲线下面积区分不同MSI状态的强大能力。与MMR-I相比,MMR-D是延长总生存期的独立预后因素(危险比= 0.340,95%CI 0.126,0.919; P = 0.034)。 MMR-D是获得更好预后的独立预后因素。我们的结果可能为个体化CRC诊断和治疗提供证据,但这需要在更大的样本研究中进一步验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号